Helmsley Charitable Trust Grants $4.3 Million to Develop Tools for the Clinical Testing of Anti-fibrotic Treatments for Crohn’s Disease Patients
15. April 2019 12:32 ET
|
The Leona M. and Harry B. Helmsley Charitable Trust
New York, NY, April 15, 2019 (GLOBE NEWSWIRE) -- The Leona M. and Harry B. Helmsley Charitable Trust has awarded $4.3 million to Cleveland Clinic, Mayo Clinic, and Robarts Clinical Trials, Inc. to...
Helmsley Charitable Trust Announces Funding Opportunity to Advance Disruptive Technologies for Type 1 Diabetes
16. Januar 2018 16:45 ET
|
The Leona M. and Harry B. Helmsley Charitable Trust
New York, NY, Jan. 16, 2018 (GLOBE NEWSWIRE) -- The Leona M. and Harry B. Helmsley Charitable Trust’s Type 1 Diabetes (T1D) Program today announced a funding opportunity through the new Future...
Helmsley Charitable Trust Awards $52 Million to Support the Global Platform for the Prevention of Autoimmune Diabetes
06. November 2017 09:00 ET
|
The Leona M. and Harry B. Helmsley Charitable Trust
New York, NY, Nov. 06, 2017 (GLOBE NEWSWIRE) -- The Leona M. and Harry B. Helmsley Charitable Trust today announced five new grants that will support the European, multinational Global Platform for...
Helmsley Grants $5 Million to Study Rise of Crohn's Disease in the East
28. März 2017 09:09 ET
|
The Leona M. and Harry B. Helmsley Charitable Trust
NEW YORK, N.Y., March 28, 2017 (GLOBE NEWSWIRE) -- The Leona M. and Harry B. Helmsley Charitable Trust has provided a total of $5.2 million to the Australasian Gastro Intestinal Research Foundation...
Helmsley Charitable Trust and Akston Biosciences Corporation Announce Partnership to Advance Novel Technology to Treat Type 1 Diabetes
16. März 2017 09:33 ET
|
The Leona M. and Harry B. Helmsley Charitable Trust
NEW YORK, NY and BEVERLY, MA, March 16, 2017 (GLOBE NEWSWIRE) -- The Leona M. and Harry B. Helmsley Charitable Trust and Akston Biosciences Corporation today announced a partnership to advance...
Helmsley Charitable Trust and Akston Biosciences Corporation Announce Partnership to Advance Novel Technology to Treat Type 1 Diabetes
16. März 2017 09:33 ET
|
The Leona M. and Harry B. Helmsley Charitable Trust
NEW YORK, NY and BEVERLY, MA, March 16, 2017 (GLOBE NEWSWIRE) -- The Leona M. and Harry B. Helmsley Charitable Trust and Akston Biosciences Corporation today announced a partnership to advance...
FasterCures to Further Accelerate Biomedical Innovation with $3 Million Grant from Helmsley Charitable Trust
14. März 2017 09:36 ET
|
The Leona M. and Harry B. Helmsley Charitable Trust
NEW YORK, March 14, 2017 (GLOBE NEWSWIRE) -- The Leona M. and Harry B. Helmsley Charitable Trust has awarded FasterCures, a center of the Milken Institute, a three-year, $3 million grant to support...
Helmsley Charitable Trust Awards $2.1 Million to Penn, Stanford and Seattle Children's Research Institute to Explore Cell-Based Therapies for Type 1 Diabetes
07. April 2016 09:05 ET
|
The Leona M. and Harry B. Helmsley Charitable Trust
NEW YORK, April 7, 2016 (GLOBE NEWSWIRE) -- The Type 1 Diabetes (T1D) Program of The Leona M. and Harry B. Helmsley Charitable Trust has announced $2.1 million in grants to support research toward the...
Helmsley Charitable Trust Awards $3.4 Million to DreaMed Diabetes for Type 1 Diabetes Decision Support
03. Februar 2016 16:22 ET
|
The Leona M. and Harry B. Helmsley Charitable Trust
NEW YORK, N.Y., Feb. 3, 2016 (GLOBE NEWSWIRE) -- The Type 1 Diabetes Program of The Leona M. and Harry B. Helmsley Charitable Trust today announced a $3.4 million grant for DreaMed Diabetes (DreaMed)....
Public Mapping and Data Tool Creates New Way to Visualize and Analyze Well-Being and Inequality in New York City
28. Oktober 2015 08:14 ET
|
The Leona M. and Harry B. Helmsley Charitable Trust
NEW YORK, Oct. 28, 2015 (GLOBE NEWSWIRE) -- The nonprofit Measure of America today released DATA2GO.NYC, a free, easy-to-use mapping and data tool that brings together for the first time federal,...